Non-alcoholic fatty liver disease and dyslipidemia: An update.

导出 LinkOut

翻译打印收藏纠错

作者： Niki,Katsiki ^[1] ; Dimitri P,Mikhailidis ^[2] ; Christos S,Mantzoros ^[3]

作者单位： Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece. ^[1] Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free Hospital Campus, University College London Medical School, University College London (UCL), London, UK. Electronic address: MIKHAILIDIS@aol.com. ^[2] Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. ^[3]

关键词 Antidiabetic drugs Dyslipidemia Ezetimibe Non-alcoholic fatty liver disease Statins

主题词疾病恶化(Disease Progression);血脂异常(Dyslipidemias);人类(Humans);胰岛素抗药性(Insulin Resistance);肝(Liver);氧化性应激(Oxidative Stress)

DOI 10.1016/j.metabol.2016.05.003

PMID 27237577

发布时间 2022-03-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交